Current Drug Safety (CDS)

Current Drug Safety is an international, peer reviewed scientific journal that focuses on research and critical reviews related to the safety evaluation of pharmaceutical agents and therapeutic products. The journal provides a specialized platform for disseminating knowledge on adverse drug reactions, toxicological profiles, and risk assessment strategies that are essential for safe and effective clinical use of medicines. It aims to support healthcare professionals, researchers, and regulatory authorities in understanding and managing drug related risks throughout the product life cycle. The scope of the journal includes pharmacovigilance, pharmacoepidemiology, post marketing surveillance, drug induced toxicity, and mechanisms underlying adverse effects at molecular, cellular, and systemic levels. It also addresses safety concerns associated with drug interactions, long term drug exposure, misuse, and off label applications. Studies involving preclinical models, clinical data, and real world evidence are all considered within its coverage. Current Drug Safety publishes original research articles, full length reviews, mini reviews, and case reports that contribute to improving drug safety monitoring and decision making. By promoting evidence based evaluations and global perspectives, the journal plays an important role in advancing safer pharmacotherapy and improving public health outcomes worldwide.

Current Drug Safety (CDS) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Pharmacology (medical), Pharmacology (nursing), Pharmacy , Online or Print , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1574-8863, E-ISSN: 2212-3911, Established: 2006, Impact Factor: 0.7
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE